🇺🇸 FDA
Pipeline program

BG-A3004

BG-A3004-101

Phase 1 mab active

Quick answer

BG-A3004 for Skin Diseases is a Phase 1 program (mab) at BeOne Medicines with 1 ClinicalTrials.gov record(s).

Program details

Company
BeOne Medicines
Indication
Skin Diseases
Phase
Phase 1
Modality
mab
Status
active

Clinical trials